Here are relevant reports on : stem-education-market
-
Biopreservation Market by Product (Media [Cryopreservation, Hypothermic]), Equipment (Freezers, Refrigerators, Incubators, Centrifuge, Accessories), Biospecimen (Tissues, Organs, Stem Cells), Application (Research, Therapeutic) - Global Forecast to 2029
The global biopreservation market, valued at US$3.7 billion in 2022, stood at US$4.4 billion in 2024 and is projected to advance at a resilient CAGR of 9.8% from 2024 to 2029, culminating in a forecasted valuation of US$7.1 billion by the end of the period. The market will grow as a result of growing advancements in the biobanks and increase in the trend of preserving newborn cord blood stem cells and rise in the need for personalized medicines.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada), Europe, APAC, RoW) - Global Forecast to 2028
The market size for synthetic stem cells is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period. The ethical concerns on the use of embryonic stem cells and the risk of tumor formation and immune response to natural stem cells are the key factors driving the growth of this market. The key developers of synthetic stem cell technology are North Carolina State University (NCSU) (US) and Zhengzhou University (China).
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023
The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) & Region - Global Forecasts to 2023
The global apoptosis assays market is projected to reach USD 5.9 billion by 2023, at a CAGR of 10.5%. The prominent players in the apoptosis assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), GE Healthcare (US), Sartorius AG (Germany), Danaher Corporation (US), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Animal Stem Cell Therapy Market by Type (Allogeneic, Autologous), Species (Dog, Cat & Horse), End User (Veterinary Hospital, Research Organization) - Global Forecast to 2027
The global animal stem cell therapy market size is projected to reach USD 0.3 billion by 2027 from USD 0.2 million in 2022, at a CAGR of 5.2% during the forecast period. The growth in the cases of various health issues such as arthritis, degenerative joint disorders, and tendon injuries in animals. This factor is encouraging the development of the global animal stem cell therapy market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Tissue Engineering Market by Product (Scaffolds (Collagen, Stem Cell), Tissue Grafts (Allograft, Autograft, Xenograft)), Material (Biological, Synthetic), Application (Orthopedics, Dermatology, Wound Care, Cardiovascular) - Global Forecast to 2028
The global tissue engineering market, valued at US$4.3 billion in 2022, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 15.3% from 2023 to 2028, culminating in a forecasted valuation of US$8.9 billion by the end of the period. The growth of this market is largely driven by the emergence of promising technologies, including 3D bioprinting, and rising demand for advanced solutions for damaged tissue repair and regeneration.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Cartilage Repair Market | Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-Cell (Tissue Scaffolds)), Application (Hyaline, Fibrocartilage), Site, and Region - Global Forecast to 2028
The global cartilage repair market, valued at US$1.1 billion in 2022, stood at US$1.3 billion in 2023 and is projected to advance at a resilient CAGR of 17.2% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. Growth in this market is mainly driven by the Increasing incidence of osteoarthritis, Increasing research funding and investments and the rising number of sports and accident-related orthopedic injuries.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Stem Cell Assays Market Size by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2027
The size of global stem cell assays market in terms of revenue was estimated to be worth USD 1.9 billion in 2022 and is poised to reach USD 4.5 billion by 2027, growing at a CAGR of 17.7% from 2022 to 2027. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) & Region - Global Forecast to 2029
The global autologous stem cell & non-stem cell therapies market, valued at US$3.9 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2029, culminating in a forecasted valuation of US$22.2 billion by the end of the period. The major factors driving the growth of this market are the rising regulatory approvals for autologous CAR T cell therapies, increasing R&D investments in autologous therapeutics, and growing demand for personalized medicines.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Mobile Cloud Market by Application (Gaming, Entertainment, Utilities, Education, Productivity, Business & Finance, Social Networking, Healthcare, Travel & Navigation), & By User (Enterprise User, Consumer) - Worldwide Market Forecast and Analysis (2014 - 2019)
In the recent years, there has been a considerable growth in the mobile and cloud technologies. Mobile communications have radically altered the business functionalities all over the globe. At the same time, cloud computing has also transformed the way of delivering services and maintenance of IT infrastructure. Global mobile cloud market to grow from $9.43 billion in 2014 to $46.90 billion by 2019, at a CAGR of 37.8% during the forecast period 2014-2019.
- Published: August 2014
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
